Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |